Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH)-Reference-Cited by-同舟云学术

Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH)

Published:2007-10-11 Issue:1 Volume:22 Page:132-137
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Luquet I,Laï J L,Barin C,Baranger L,Bilhou-Nabera C,Lippert E,Gervais C,Talmant P,Cornillet-Lefebvre P,Perot C,Nadal N,Mozziconacci M J,Lafage-Pochitaloff M,Eclache V,Mugneret F,Lefebvre C,Herens C,Speleman F,Poirel H,Tigaud I,Cabrol C,Rousselot P,Daliphard S,Imbert M,Garand R,Geneviève F,Berger R,Terre C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404974.pdf

Reference22 articles.

1. Brunning RD, Matutes E, Harris NL, Flandrin G, Vardiman J, Bennett J et al. Acute myeloid leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001 pp 75–108.

2. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al., On behalf of the Medical Research Council Adult and Children's Leukemia Working Parties. The importance of diagnosis cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322–2333.

3. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al., For the Southwest Oncology Group and the Eastern Cooperative Oncology Group. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukaemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000; 96: 4075–4083.

4. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukaemia: results from Cancer and Leukaemia Group B (CALGB 8461). Blood 2002; 100: 4325–4336.

5. Kern W, Haferlach T, Schoch C, Löffler H, Gassmann W, Heinecke A et al. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood 2003; 101: 64–70.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China;Annals of Hematology;2024-06-08

2. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype;Bone Marrow Transplantation;2023-12-13

3. Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia with Hyperdiploid Complex Karyotype;2023-06-26

4. Chromosomal aberrations and prognostic analysis of secondary acute myeloid leukemia—a retrospective study;PeerJ;2023-05-15

5. Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia;Haematologica;2023-02-23